SAN DIEGO, June 29, 2021 /PRNewswire/ -- Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced the close of a $276 million Series C financing. New ...

Element Biosciences, an Illumina rival, on its genomics ambitions — and why it hasn’t gone public. By Jonathan Wosen May 14, 2024. Reprints. Element Biosciences exterior Element Biosciences.

SAN DIEGO, Feb. 6, 2024 /PRNewswire/ -- Element Biosciences, Inc., developer of pioneering technologies to empower science, announced a collaboration with DNAnexus, provider of the Precision ...

Element Biosciences closed its acquisition of Loop Genomics, a long-read company that enables short-read sequencers to obtain long range information.

With its DNA sequencing platform Aviti, San Diego-based startup Element Biosciences is among the many players in this R&D sandbox. Today, the company announced that it has raised a $277 million ...

Yaron Hakak, senior vice president of corporate and business development, Element Biosciences. By Contributed Content UPDATED: September 3, 2023 at 7:04 AM PDT ...

Direct integration allows customers to stream data from Element's AVITI™ System directly to DNAnexus SAN DIEGO, Feb. 6, 2024 /PRNewswire/ -- Element Biosciences, Inc., developer of pioneering ...